| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kintara Therapeutics, Inc. | Director | Options (Right to Buy) | 8,500 | 30 Aug 2023 | Direct | ||
| LA JOLLA PHARMACEUTICAL CO | Director | Common Stock | 0 | $6.23 | 22 Aug 2022 | Direct | |
| LA JOLLA PHARMACEUTICAL CO | Director | Stock Option (Right to Buy) | 0 | 22 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HURA | Kintara Therapeutics, Inc. | 30 Aug 2023 | 1 | $0 | 4 | Director | 01 Sep 2023, 19:00 |
| /report/000089924322029651-johnson-laura-l-2022-08-22 | LA JOLLA PHARMACEUTICAL CO | 22 Aug 2022 | 11 | -$3,115 | 4 | Director | 24 Aug 2022, 20:18 |
| HURA | Kintara Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 05 Jul 2022, 16:05 |
| /report/000120919122003403-johnson-laura-l-2022-01-12 | LA JOLLA PHARMACEUTICAL CO | 12 Jan 2022 | 1 | $0 | 4 | Director | 14 Jan 2022, 20:00 |
| HURA | Kintara Therapeutics, Inc. | 22 Nov 2021 | 1 | +$2,227 | 4 | Director | 24 Nov 2021, 15:06 |
| HURA | Kintara Therapeutics, Inc. | 22 Sep 2021 | 1 | $0 | 4 | Director | 22 Sep 2021, 20:31 |